NVAXNOVAVAX INC

Nasdaq novavax.com


$ 4.76 $ -0.07 (-1.44 %)    

Thursday, 28-Mar-2024 15:59:59 EDT
QQQ $ 443.93 $ -0.82 (-0.18 %)
DIA $ 397.72 $ 0.20 (0.05 %)
SPY $ 523.07 $ -0.10 (-0.02 %)
TLT $ 94.55 $ -0.08 (-0.08 %)
GLD $ 205.72 $ 2.62 (1.29 %)
$ 4.78
$ 4.87
$ 0.00 x 0
$ 0.00 x 0
$ 4.76 - $ 4.94
$ 3.53 - $ 11.36
3,599,271
na
481.67M
$ 0.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-28-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-10-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-10-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-11-2020 12-31-2019 10-K
18 11-07-2019 09-30-2019 10-Q
19 08-07-2019 06-30-2019 10-Q
20 05-02-2019 03-31-2019 10-Q
21 03-18-2019 12-31-2018 10-K
22 11-07-2018 09-30-2018 10-Q
23 08-08-2018 06-30-2018 10-Q
24 05-09-2018 03-31-2018 10-Q
25 03-14-2018 12-31-2017 10-K
26 11-07-2017 09-30-2017 10-Q
27 08-08-2017 06-30-2017 10-Q
28 05-08-2017 03-31-2017 10-Q
29 02-27-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 05-05-2016 03-31-2016 10-Q
33 02-29-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-07-2015 03-31-2015 10-Q
37 02-27-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 08-07-2014 06-30-2014 10-Q
40 05-08-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 novavax-inc-says-canada-national-advisory-committee-publishes-recommendation-for-use-of-novavaxs-nuvaxovid-xbb15-covid-19-vaccine-recommendations-state-that-nuvaxovid-xbb15-can-be-used-in-unvaccinated-or-previously-vaccinated-individuals-aged-12-years-and-older

- Reuters

 novavax-says-canada-national-advisory-committee-publishes-recommendation-for-use-of-novavaxs-nuvaxovid-xbb15-covid-19-vaccine-recommendations-state-that-nuvaxovid-xbb15-can-be-used-in-unvaccinated-or-previously-vaccinated-individuals-aged-12-years-and-older

- Reuters

 hc-wainwright--co-maintains-buy-on-novavax-lowers-price-target-to-19

HC Wainwright & Co. analyst Vernon Bernardino maintains Novavax (NASDAQ:NVAX) with a Buy and lowers the price target fro...

 why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

 why-is-covid-19-vaccine-maker-novavax-stock-plunging-on-wednesday

Novavax reports Q4 2023 revenue of $291 million, missing consensus. Restructuring brings 30% workforce reduction. Anticipates C...

 novavax-q4-gaap-eps-144-may-not-be-comparable-to-045-estimate-sales-29134m-miss-32197m-estimate

Novavax (NASDAQ:NVAX) reported quarterly losses of $(1.44) per share which missed the analyst consensus estimate of $(0.45) by ...

 novavax-fy-eps-541-up-from-842-yoy-sales-98371m-down-from-198b-yoy

Novavax (NASDAQ:NVAX) reported quarterly losses of $(5.41) per share. This is a 35.75 percent increase over losses of $(8.42) p...

 novavax-says-upon-restructuring-completion-resulting-company-workforce-is-expected-to-be-approximately-30-lower-as-compared-to-1q23-end

In May 2023, the company announced a global restructuring and cost reduction plan. Additionally, in January 2024 it announced a...

 earnings-scheduled-for-february-28-2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

 beyond-meat-viking-therapeutics-novavax-baidu-tesla-why-these-5-stocks-are-on-investors-radars-today

The U.S. indices were mixed with the S&P 500 rising by nearly 0.2% to 5,078.18 and the Dow Jones Industrial Average falling...

 novavaxs-earnings-outlook
Novavax's Earnings Outlook
02/27/2024 18:01:17

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION